LLY Earnings Play LONG ( Flat Bottom Triangle Breakout)My analysis is on the 2H. I am uniquely qualified in my fundamental analysis. This is a one
day until earnings. My thesis is the earnings will stimulate what will be a breakout from
a flat bottom triangle. I will buy one share of stock. I will spend a similar amount on
call options striking $460 expiring August 11th. I see LLY as surging while PFE is a bit
challenged with the fall off in Covid vaccine work. If you find this idea interesting and
might appreciate my ideas as to a stop loss and targets, leave a comment. Like and
subscribe. Trade well !
LLY
LLY Eli Lilly Options Ahead of EarningsAnalyzing the options chain and the chart patterns of LLY Eli Lilly prior to the earnings report this week,
I would consider purchasing the 450usd strike price Calls with
an expiration date of 2023-8-11,
for a premium of approximately $11.70.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Looking forward to read your opinion about it.
PFE Large Cap Pharma increased its dividendPFE just raised its dividend On the chart it has been trending downward
as shown also by a down sloping anchored VWAP bands. Price is currently
sitting at long term support and two standard deviations below VWAP.
It appears to be ready to reverse from the deep undervalued area.
In confirmation, teh voume indicator shows moderate increased relative
volume compared with March. I see this as a good opportunity to enter
a swing long trade or investment. PFE has its increased dividend as a
hint to shareholders of increasing earnings also with the next generation of
COVID vaccines in the pipeline along with a diversified line of other
products. The only thing that will slow PFE down in federal legislation to
limit the retail MSRP prices of its products to all consumers including those
with no insurance and commercial coverage outside federal programs.
PFE is solid as a rock. I see the buy signal.
LLY - Rising Trend Channel [Mid Term]- LLY is in a rising trend channel in the medium long term.
- LLY has also received a positive signal from the moving average indicator, thus signaling a continued rise.
- LLY has broken up through resistance at 375.
- The short term momentum of the stock is strongly positive, with RSI above 70.
- Overall assessed as technically positive for the medium long term.
*EP: Enter Price, SL: Support, TP: Take Profit, CL: Cut Loss, TF: Time Frame, RST: Resistance, RTS: Resistance to be Support LT TP: Long Term Target Price
*Chart Pattern:
DT - Double Top | BEARISH | RED
DB - Double Bottom | BULLISH | GREEN
HNS - Head & Shoulder | BEARISH | RED
REC - Rectangle | BLUE
iHNS - inverse head & Shoulder | BULLISH | GREEN
Verify it first and believe later.
WavePoint ❤️
ELI LILLY on the best buy opportunity of the year!Eli Lilly and Company (LLY) has been trading within a Channel Up pattern since the October 30 2020 low exactly on the 1W MA100 (red trend-line). As the 1D RSI turned oversold below the 30.00 barrier, while the price touched the bottom (Higher Lows trend-line) of the Channel Up, it has filled all conditions for the most optimal buy level of the year. There have been another three similar oversold events, each on one year since 2020.
Once the price breaks above the 1D MA200 (orange trend-line) again, which you can use as confirmation and take the buy after it, we'll set a target at $390.00 on a 4 month horizon.
-------------------------------------------------------------------------------
** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! **
-------------------------------------------------------------------------------
💸💸💸💸💸💸
👇 👇 👇 👇 👇 👇
LLY | LongThis week a Twitter user bought a blue tick by spending $8 to post a fake tweet "insulin will be free now". Major Insulin producer LLY erased $30 billion in market cap. in a single day. Fundamentally this stock has a huge P/E ratio, in spide, there still has growth potential for that underlying. IMO LLY will retest new highs.
LLYthe health services and health technology sectors were the first to receive investment and bullish speculative pressures as the dollar fell
that is, drugs and vaccines never go into crisis .. even LLY has never even dropped below the 200 daily moving average this year, like very few stocks
and has now confirmed a bullish symmetrical triangle, I buy now and on GAP 343 retracement
MSFT SHORT
study(title="BestIntradayTips", shorttitle="BIT", precision=0, overlay=true, scale=scale.left)
trendDetectionLength=input(2)
showDistributionBelowZero=input(false, type=bool)
mov = close>close ? 1 : close= dif
wave=(trend != nz(wave )) and isTrending ? trend : nz(wave )
vol=wave==wave ? (nz(vol )+volume) : volume
up=wave == 1 ? vol : 0
dn=showDistributionBelowZero ? (wave == 1 ? 0 : wave == -1 ? -vol : vol) : (wave == 1 ? 0 : vol)
input_src = wave == 1 ? vol : 0
input_ma_period = input(50, title="Moving average")
input_max_height = input(1000, title="Maximum value on left bar")
ma = sma(input_src, input_ma_period)
normalized_volume = min(input_src / ma * 100, input_max_height * 1)
plot(input_max_height, transp=100, title="")
//
input_src1 = showDistributionBelowZero ? (wave == 1 ? 0 : wave == -1 ? -vol : vol) : (wave == 1 ? 0 : vol)
input_ma_period1 = input(50, title="Moving average")
input_max_height1 = input(1000, title="Maximum value on left bar")
hline(0)
hline(250)
hline(500)
hline(750)
ma1 = sma(input_src1, input_ma_period1)
normalized_volume1 = min(input_src1 / ma1 * 100, input_max_height1 * 1)
resCustom = input(title="Timeframe", type=resolution, defval="1440" )
v=security(tickerid, resCustom,normalized_volume)
resCustom1 = input(title="Timeframe", type=resolution, defval="1440" )
v1=security(tickerid, resCustom,normalized_volume1)
a=v>0 and v1<50
b=v1>0 and v<50
bgcolor(a > 0 ? blue : na, transp=80)
bgcolor(b > 0 ? red : na, transp=80)
$LLY looks ready to breakout$LLY daily chart. IT closed nicely on Friday even though most of the stocks were down a lot. After an up move, it is now moving sideways inside this rectangular range. Looks ready for next upmove once we break this range on the upside. Once we break above 335, looking for a 8% up move in this one.
7/17/22 LLYEli Lilly and Company ( NYSE:LLY )
Sector: Health Technology (Pharmaceuticals: Major)
Market Capitalization: $315.073B
Current Price: $331.60
Breakout price: $334.70
Buy Zone (Top/Bottom Range): $314.00-$292.90
Price Target: $364.20-$367.50 (2nd)
Estimated Duration to Target: 112-120d (2nd)
Contract of Interest: $LLY 10/21/22 350c
Trade price as of publish date: $13.50/contract
3/13/22 LLYEli Lilly and Company ( NYSE:LLY )
Sector: Health Technology (Pharmaceuticals: Major)
Market Capitalization: $253.61B
Current Price: $266.30
Breakout price: $270.95 (hold above)
Buy Zone (Top/Bottom Range): $262.45-$247.10
Price Target: $308.00-$310.40
Estimated Duration to Target: 84-90d
Contract of Interest: $LLY 6/17/22 300c
Trade price as of publish date: $5.90/contract